Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)"

Circulation. 2016 May 17;133(20):e661. doi: 10.1161/CIRCULATIONAHA.116.021847.

Authors

Mandana Nikpour¹, David Prior¹, David Celermajer²

Affiliations

¹ The University of Melbourne at St. Vincent's Hospital Melbourne Australia.
² The University of Sydney at Royal Prince Alfred Hospital Sydney Australia.

PMID: 27185030
DOI: 10.1161/CIRCULATIONAHA.116.021847

No abstract available

Publication types

Letter
Comment

MeSH terms

Disease Management
Familial Primary Pulmonary Hypertension*
Humans
Hypertension, Pulmonary
Registries
Survival Rate
Warfarin*

Substances

Warfarin